Assays for protein degradation therapeutics to accelerate undruggable proteome discoveries
Looking for a way to address the undruggable proteins in the human body? Sign up for our free live webinar where industry experts will discuss strategies to accelerate TPD drug discovery efforts using high-throughput cell-based assays.
Key takeaways from the AACR Meeting 2022
By Victoria Rees (Drug Target Review)
Biodegradable gel boosts immune system’s attack on several cancers in mice
By Ria Kakkad (Drug Target Review)
COVID vaccine that could protect against Omicron and other variants
By Ria Kakkad (Drug Target Review)
The promise of mRNA therapeutics in producing the first regenerative treatment for SUI
By Dr Roger Dmochowski (Vanderbilt University Medical Center)
Cell line development tactics and strategies for faster Investigational New…
By Soojin Han (Samsung Biologics America)
Viewing disease through the lens of memory B cells: improving…
By Dr Purnanand Sarma (Immunome)
Neutralising SARS-CoV-2 with intranasally-delivered antibodies
By Dr Chris Takimoto (IGM Biosciences)
Emerging trends in biotherapeutic development
By Dr Andrew Bradbury (Specifica), Dr Bryan Jones (Eli Lilly…